U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C11H15N2O2S.Na
Molecular Weight 262.304
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTHALITAL SODIUM

SMILES

[Na+].CC(C)CC1(CC=C)C(=O)NC(=S)[N-]C1=O

InChI

InChIKey=APSWQQYXFMUODF-UHFFFAOYSA-M
InChI=1S/C11H16N2O2S.Na/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15;/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16);/q;+1/p-1

HIDE SMILES / InChI
Molecular Formula C11H16N2O2S
Molecular Weight 240.322
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Buthalital is a barbiturate derivative which was under development as a short-acting anesthetic. However, development was discontinued, perhaps due to its extremely rapid elimination rate] and buthalital sodium was never marketed.

Originator

Approval Year

Unknown
149124
Patents

Patents

4684728
2
GB468683
2
Substance Class Chemical
Created
by admin
on Mon Mar 31 19:25:35 GMT 2025
Edited
by admin
on Mon Mar 31 19:25:35 GMT 2025
Record UNII
810E8N9VUG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUTHALITAL SODIUM
INN  
INN  
Official Name English
BUTHALITAL SODIUM SALT
MI  
Preferred Name English
SODIUM 5-ALLYL-5-ISOBUTYL-2-THIOBARBITURATE
Systematic Name English
BAYTINAL
Brand Name English
buthalital sodium [INN]
Common Name English
4,6(1H,5H)-PYRIMIDINEDIONE, DIHYDRO-5-(2-METHYLPROPYL)-5-(2-PROPEN-1-YL)-2-THIOXO-, SODIUM SALT (1:1)
Common Name English
THIALISOBUMAL SODIUM
Common Name English
BUTHALITAL SODIUM SALT [MI]
Common Name English
Code System Code Type Description
ChEMBL
CHEMBL2110937
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY
INN
565
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY
CAS
510-90-7
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY
MERCK INDEX
m1049
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY Merck Index
EPA CompTox
DTXSID40965285
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY
NCI_THESAURUS
C171747
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY
PUBCHEM
23690453
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY
FDA UNII
810E8N9VUG
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY
SMS_ID
300000036875
Created by admin on Mon Mar 31 19:25:35 GMT 2025 , Edited by admin on Mon Mar 31 19:25:35 GMT 2025
PRIMARY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966